Preliminary study of hepatocyte-specific MR contrast agent in the evaluation of liver function

LUO Yan-ji,CAI Hua-song,TANG Di,WU Ling,PENG Zhen-peng,LI Zi-ping,ZHENG Ke-guo,YIN Xiao-yu,FENG Shi-ting
DOI: https://doi.org/10.3877/cma.j.issn.2095-2015.2013.05.006
2013-01-01
Abstract:Objective To analyze the signal intensity changes of different liver function patients after the injection with hepatocyte-specific contrast agent gadolinium ethoxybenzyl diethylene-triamine pentaacetic acid( Gd-EOB-DTPA),and to explore the application of Gd-EOB-DTPA in liver function evaluation. Methods 28 patients underwent Gd-EOB-DTPA-enhanced MRI. All cases were classied as Child-Pugh class A in 15 patients,Child-Pugh class B in 9 patients,and Child-Pugh class C in 4 patients. We chose region of interest( ROI) of each patients at the same level of liver and paraspinal muscle on axial image,measured the signal intensity of ROI of anti-phase before( S1,S2) and after( S3,S4) contrast agent injection,and calculated Ratio 1 and Ratio 2( Ratio1 = S1 / S2,Ratio2 = S3 / S4),then calculated IS%( Increased Signal% =( Ratio2-Ratio1) / Ratio2 × 100%) to show hepatic enhancement degree. Finally,the difference of IS% between the two groups was analyzed. Results IS% of liver function with Child-Pugh Class A was higher than B and C,and the differences between Child-Pugh Class A and B( P = 0. 000), between Child-Pugh Class A and C( P = 0. 000) were statistically significant,but the difference between Child-Pugh Class B and C was not statistically significant( P = 0. 318). Conclusions Gd-EOB-DTPA- enhanced MRI can reflect the hepatocyte function to some extent,which can be used as a new method in liver function evaluation.
What problem does this paper attempt to address?